Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | EVP, Chief Legal Officer | Common Stock | 5.13K | $951K | $185.32 | Aug 5, 2021 | Direct |
ALNYLAM PHARMACEUTICALS, INC. | EVP, Chief Legal Officer | Common Stock | 434 | $80.4K | $185.32 | Aug 5, 2021 | by Managed Account |
Immuneering Corp | Director | Stock Option | 33.4K | Jun 12, 2024 | Direct | ||
PepGen Inc. | Director | Stock Option (Right to Buy) | 13K | Jun 20, 2024 | Direct | ||
ALNYLAM PHARMACEUTICALS, INC. | EVP, Chief Legal Officer | Performance Stock Option 2015 (right to buy) | 11.9K | Aug 5, 2021 | Direct | ||
ALNYLAM PHARMACEUTICALS, INC. | EVP, Chief Legal Officer | Stock Option (right to buy) | 1.12K | Aug 5, 2021 | Direct | ||
Imago BioSciences, Inc. | Director | Stock Option (Right to Buy) | 0 | Jan 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PEPG | PepGen Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
IMRX | Immuneering Corp | Jun 12, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
IMRX | Immuneering Corp | Jan 1, 2024 | 1 | $0 | 4 | Jan 2, 2024 | Director |
PEPG | PepGen Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
IMRX | Immuneering Corp | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
IMGO | Imago BioSciences, Inc. | Jan 11, 2023 | 2 | $0 | 4 | Jan 11, 2023 | Director |
IMRX | Immuneering Corp | Jun 21, 2022 | 1 | $0 | 4 | Jun 23, 2022 | Director |
IMGO | Imago BioSciences, Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
IMRX | Immuneering Corp | May 16, 2022 | 1 | $35K | 4 | May 17, 2022 | Director |
PEPG | PepGen Inc. | May 6, 2022 | 1 | $50K | 4 | Jan 19, 2023 | Director |
PEPG | PepGen Inc. | May 6, 2022 | 1 | $0 | 4 | May 10, 2022 | Director |
PEPG | PepGen Inc. | May 5, 2022 | 0 | $0 | 3 | May 5, 2022 | Director |
IMGO | Imago BioSciences, Inc. | Nov 17, 2021 | 1 | $0 | 4 | Nov 19, 2021 | Director |
IMGO | Imago BioSciences, Inc. | Nov 17, 2021 | 0 | $0 | 3 | Nov 19, 2021 | Director |
ALNY | ALNYLAM PHARMACEUTICALS, INC. | Aug 5, 2021 | 5 | -$1M | 4 | Aug 9, 2021 | EVP, Chief Legal Officer |
IMRX | Immuneering Corp | Aug 3, 2021 | 1 | $105K | 4 | Aug 4, 2021 | Director |
IMRX | Immuneering Corp | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Director |
ALNY | ALNYLAM PHARMACEUTICALS, INC. | Jul 12, 2021 | 6 | -$620K | 4 | Jul 14, 2021 | EVP, Chief Legal Officer |
ALNY | ALNYLAM PHARMACEUTICALS, INC. | Jun 9, 2021 | 1 | -$267K | 4 | Jun 11, 2021 | EVP, Chief Legal Officer |